Results 61 to 70 of about 14,856,300 (187)

B-cell lymphoma showing typical features of angioimmunoblastic T-cell lymphoma [PDF]

open access: yes, 2008
We present a 52-year-old man who was diagnosed with B cell-derived angioimmunoblastic lymphoma. He was admitted with systemic, including mediastinal and para-aortic, lymphadenopathy, fever and skin itching.
Ozawa, Keiya   +5 more
core  

Mechanisms of Rejection of High Grade B cell Lymphoma in Mice [PDF]

open access: yes, 2008
The incidence of high grade B cell lymphoma in western countries has increased over the last decades. Improvement of conventional chemotherapy regimens has significantly contributed to prolonged 5-year survival rates which currently reach around 60 ...
Sukumar, Madhusudhanan
core   +1 more source

EBV-positive immunodeficiency lymphoma after alemtuzumab-CHOP therapy for peripheral T-cell lymphoma

open access: yes, 2008
Chemotherapy with alemtuzumab and the combination of cyclophosphamide, adriamycin, oncovin, and prednisone (CHOP) has become experimental trial therapy for aggressive T-cell lymphoma. Several multicenter phase 3 trials; will incorporate this scheme.
Coenen, Jules L.   +4 more
core   +1 more source

Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified

open access: yesHaematologica, 2018
Due to heterogeneous morphological and immunophenotypic features, approximately 50% of peripheral T-cell lymphomas are unclassifiable and categorized as peripheral T-cell lymphomas, not otherwise specified.
Meng-Meng Ji   +13 more
doaj   +1 more source

The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project

open access: yes, 2009
BACKGROUND: The International Peripheral T-cell Lymphoma Project was organized to better understand the T-cell and natural killer (NK) cell lymphomas, and our task is to present the clinicopathologic correlations and therapeutic results for adult T-cell
Ullrich F   +64 more
core   +1 more source

The potential therapeutic role of selenium in diffuse large B-cell lymphoma [PDF]

open access: yes, 2011
PhDThe clinical background to this work confirms the very poor outcome of patients with recurrent diffuse large B-cell lymphoma (DLBCL) and highlights the need for better therapies.
Kassam, Shireen
core   +3 more sources

TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma [PDF]

open access: yes, 2009
Proliferation and survival of Hodgkin and Reed/Sternberg (HRS) cells, the malignant cells of classical Hodgkin lymphoma (cHL), are dependent on constitutive activation of nuclear factor {kappa}B (NF-{kappa}B).
Inga Vater   +25 more
core   +1 more source

Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients

open access: yesBMC Cancer, 2019
Background Regulatory immune cells may modulate the lymphoma microenvironment and are of great interest due to the increasing prevalence of treatment with immunotherapies in lymphoma patients.
R-M Amini   +7 more
doaj   +1 more source

Complete hematologic response in a patient with multiple pretreated angioimmunoblastic T‐cell lymphoma after belinostat therapy followed by allogeneic stem cell transplantation: A case report

open access: yesClinical Case Reports
Key Clinical Message Belinostat therapy followed by hematopoietic stem cell transplantation is a promising salvage strategy for heavily pretreated patients with peripheral T‐cell lymphoma.
Sigrid De Wilde, Carlos Graux
doaj   +1 more source

Primary renal peripheral T‐cell lymphoma, not otherwise specified, treated with partial nephrectomy

open access: yesIJU Case Reports
Introduction Renal involvement by non‐Hodgkin's lymphoma is very rare, and the kidney as the primary site of this lymphoma is much more uncommon. We report a case of primary renal peripheral T‐cell lymphoma, not otherwise specified, treated with partial ...
Airi Miki   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy